| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/18/2013 | EP2637505A1 Compositions and methods for treating erectile dysfunction |
| 09/18/2013 | EP2637503A1 Selective glycosidase inhibitors and uses thereof |
| 09/18/2013 | EP2637502A1 Mutant-selective egfr inhibitors and uses thereof |
| 09/18/2013 | EP2612850B1 Delta crystalline form of the arginine salt of perindopril, a process for its preparation, and pharmaceutical compositions containing it |
| 09/18/2013 | CN1895262B Emulsion for injecting epirubicin and its production |
| 09/18/2013 | CN1697655B Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 09/18/2013 | CN1694959B Non-sequence complementary antiviral oligonucleotides |
| 09/18/2013 | CN1578779B Small organic molecule regulators of cell proliferation |
| 09/18/2013 | CN103314295A Use of bubr1 as a biomarker of drug response to furazanobenzimidazoles |
| 09/18/2013 | CN103314109A SiRNA for inhibition of Hif1a expression and anticancer composition containing same |
| 09/18/2013 | CN103314009A Regulation of glypican 4 activity to modulate the fate of stem cells and uses thereof |
| 09/18/2013 | CN103313992A Hdac inhibiting derivatives of camptothecin |
| 09/18/2013 | CN103313990A Alaninyl maytansinol antibody conjugates |
| 09/18/2013 | CN103313989A Tricyclic PI3K inhibitor compounds and methods of use |
| 09/18/2013 | CN103313988A Imidazotriazinone compounds |
| 09/18/2013 | CN103313987A Pyrazolopyridines and pyrazolopyridines and their use as tyk2 inhibitors |
| 09/18/2013 | CN103313986A Novel indolizine derivatives, and preparation and therapeutic use thereof |
| 09/18/2013 | CN103313985A Crystalline form of pyrimidio[6,1-A]isoquinolin-4-one compound |
| 09/18/2013 | CN103313982A Phenyl-isoxazol derivatives and preparation process thereof |
| 09/18/2013 | CN103313981A 2-methoxy-pyridin-4-yl derivatives |
| 09/18/2013 | CN103313978A Pyrazole aminopyrimidine derivatives as LRRK2 modulators |
| 09/18/2013 | CN103313976A SGC stimulators |
| 09/18/2013 | CN103313974A Benzimidazole respiratory syncytial virus inhibitors |
| 09/18/2013 | CN103313972A Pyrazol-4-yl carboxamide derivatives as microbiocides |
| 09/18/2013 | CN103313970A Novel bicyclic compound or salt thereof |
| 09/18/2013 | CN103313968A Nampt and rock inhibitors |
| 09/18/2013 | CN103313722A Monoterpene derivatives of chalcone or dihydrochalcone and their use as depigmenting agents |
| 09/18/2013 | CN103313719A PEG or PEG block copolymers for treating colorectal cancer |
| 09/18/2013 | CN103313718A Growth hormone secretion promoter |
| 09/18/2013 | CN103313717A Composition containing styraxlignolide A or the aglycone thereof as an active ingredient for preventing or treating asthma |
| 09/18/2013 | CN103313716A Topical compositions for preserving or restoring the integrity of mucosae |
| 09/18/2013 | CN103313715A Treatment of pain associated with dislocation of basal endometrium |
| 09/18/2013 | CN103313714A Dexamethasone combination therapy |
| 09/18/2013 | CN103313713A Use of a receptor-type kinase modulator for treating polycystic kidney disease |
| 09/18/2013 | CN103313712A Pyridazine derivatives, compositions and methods for treating cognitive impairment |
| 09/18/2013 | CN103313711A Increasing drug bioavailability in naltrexone therapy |
| 09/18/2013 | CN103313710A Patch |
| 09/18/2013 | CN103313709A Use of sigma ligands in bone cancer pain |
| 09/18/2013 | CN103313708A Method of treating contrast-induced nephropathy |
| 09/18/2013 | CN103313707A Diphenyl-amine derivatives: uses, process of synthesis and pharmaceutical compositions |
| 09/18/2013 | CN103313706A Controlled release mucoadhesive systems |
| 09/18/2013 | CN103313705A Percutaneous absorption preparation containing rivastigmine |
| 09/18/2013 | CN103313704A Highly concentrated liquid acetaminophen solutions |
| 09/18/2013 | CN103313701A Pharmaceutical compositions of pyridinium and quinolinium derivatives |
| 09/18/2013 | CN103313700A Topical gel composition |
| 09/18/2013 | CN103313696A Skin whitening agent |
| 09/18/2013 | CN103313613A Coffee extracts as ingredients of foods, drugs, cosmetics, dietary supplements, and biologics |
| 09/18/2013 | CN103313608A Agent for improving milk yield and/or milk quality of ruminants, preventive or therapeutic agent for perinatal disease, and agent for improving reproductive efficiency |
| 09/18/2013 | CN103313601A Salvinorin compositions and uses thereof |
| 09/18/2013 | CN103313599A Substituted 4-(arylamino) selenophenopyrimidine compounds and methods of use thereof |
| 09/18/2013 | CN103313597A Articles incorporating absorbert polymer and ceragenin compound |
| 09/18/2013 | CN103305567A Bacillus calmette-guerin compound polysaccharide, and preparation method and use thereof |
| 09/18/2013 | CN103305520A Aptamer sequence of hepatitis B virus core antigen, and applications thereof |
| 09/18/2013 | CN103305330A Paeonia sect.paeonia plant seed oil and preparation method and application thereof |
| 09/18/2013 | CN103304687A Preparation of full-6-(3'S-tetrahydroisoquinolin-3'-formylamino)-6-deoxy-beta-cyclodextrin and application |
| 09/18/2013 | CN103304680A Beta-glucan, and extraction method and application thereof |
| 09/18/2013 | CN103304622A Novel sea asparagus triterpenoid saponin reducing compound as well as preparation method and application thereof |
| 09/18/2013 | CN103304620A Ilicin derivatives, as well as preparation method, anti-platelet aggregation activity and application thereof |
| 09/18/2013 | CN103304619A Dienogest compound |
| 09/18/2013 | CN103304618A Triterpenoid saponin compound with anti-inflammatory activity as well as preparation method and application thereof |
| 09/18/2013 | CN103304609A Houttuynoid and preparation method and application thereof |
| 09/18/2013 | CN103304607A Monoterpene glycoside compound obtained from fat-reducing weight-losing effective part of sibiraea angustata and application thereof |
| 09/18/2013 | CN103304604A Clindamycin phosphate compound and preparation method and pharmaceutical composition thereof |
| 09/18/2013 | CN103304602A Dabigatran etexilate gluconate, and preparation method and application thereof |
| 09/18/2013 | CN103304600A Voriconazole phosphate trihydrate and preparation method and application thereof |
| 09/18/2013 | CN103304597A Creatine phosphate sodium compound and preparation method thereof, and pharmaceutical composition of compound and preparation method of composition |
| 09/18/2013 | CN103304584A 2-hydrazone-thiazolo[4,5-b]quinoxaline compounds, and preparation method and purpose thereof |
| 09/18/2013 | CN103304582A Cefoxitin sodium compound, preparation method and pharmaceutical composition thereof |
| 09/18/2013 | CN103304581A Cefminox sodium compound as well as preparation method and pharmaceutical composition of cefminox sodium compound |
| 09/18/2013 | CN103304580A Cefepime dihydrochloride compound as well as preparation method and medicine composition thereof |
| 09/18/2013 | CN103304579A ortho-positioned bridged azacrown ether modified phthalocyanin and preparation method and application thereof |
| 09/18/2013 | CN103304577A Prasugrel acid addition salts, and preparation methods and medicinal applications thereof |
| 09/18/2013 | CN103304575A Neogambogic acid derivative, preparation method thereof and pharmaceutical application |
| 09/18/2013 | CN103304573A Application of Lycorine compound in preparation of anti-tumor drugs |
| 09/18/2013 | CN103304572A 3-cyanoquinoline compound as well as pharmaceutical composition and application thereof |
| 09/18/2013 | CN103304571A Spiro compound as well as preparation method, intermediate, pharmaceutical composition and application thereof |
| 09/18/2013 | CN103304570A Naloxone hydrochloride compound as well as preparation method and pharmaceutical composition of naloxone hydrochloride compound |
| 09/18/2013 | CN103304569A Erlotinib-phthalocyanine conjugate and preparation method thereof |
| 09/18/2013 | CN103304566A Novel crystalline entecavir |
| 09/18/2013 | CN103304565A Vindoline derivative medical application |
| 09/18/2013 | CN103304564A Beta-carboline derivative containing hydroximic acid as well as preparation method and medical application thereof |
| 09/18/2013 | CN103304561A Compounds with antithrombotic effects |
| 09/18/2013 | CN103304560A Thiazolinone derivatives comprising pyrazoline and thiophene (or furan) structures, and preparation method and application thereof |
| 09/18/2013 | CN103304559A Thiazole derivatives comprising pyrazoline and thiophene (or furan) structures, and preparation method and application thereof |
| 09/18/2013 | CN103304556A Schiff base compound containing benzopyran, preparation method and use thereof |
| 09/18/2013 | CN103304555A Group of benzene-oxazolyl derivatives and preparation method as well as relevant application thereof as IMPDH (Inosine Monophosphate Dehydrogenase) inhibitor |
| 09/18/2013 | CN103304552A Substituted pyridine compound as well as application method and usage thereof |
| 09/18/2013 | CN103304551A Hepatitis C polymerase inhibitor |
| 09/18/2013 | CN103304546A Pyrazoline derivatives comprising 1,4-benzodioxan structure, and preparation method and application thereof |
| 09/18/2013 | CN103304544A Polymorphic substances of 4-(substituted anilino)quinazoline derivative xylene sulfonate, and preparation method and application thereof |
| 09/18/2013 | CN103304542A Rupatadine fumarate compound |
| 09/18/2013 | CN103304541A Viral polymerase inhibitors |
| 09/18/2013 | CN103304539A Dabigatran etexilate malate, and preparation method and application thereof |
| 09/18/2013 | CN103304537A Biphenyl cyclooctene lignans compound as well as preparation method and application thereof |
| 09/18/2013 | CN103304529A Preparation method and application of triterpenoid with immunosuppressive activity |
| 09/18/2013 | CN103304528A Red anise lactone F, extraction method thereof and application of red anise lactone F in medicine preparation |
| 09/18/2013 | CN103304523A Andrographolide derivative nitric oxide donor compound as well as preparation method and application thereof |
| 09/18/2013 | CN103304522A Compound with neuroinflammation inhibition activity, as well as preparation method and application thereof |
| 09/18/2013 | CN103304518A Sesquiterpenoids and pharmaceutical composition thereof, and application of pharmaceutical composition in pharmacy |
| 09/18/2013 | CN103304514A Acid diltiazem compound with good stability, and pharmaceutical composition |